Cargando…
Effects of simvastatin on apolipoprotein M in vivo and in vitro
OBJECTIVE: To investigate effects of lipid lowering drug, simvastatin, on apolipoprotein M expression in the hyperlipidemic mice and in hepatic cell line, HepG2 cells. METHODS: Swiss male mice were randomly divided into the high fat group and control group, and were intragastrically fed with 0.9% sa...
Autores principales: | Zhang, Xiaoying, Mao, Shubing, Luo, Guanghua, Wei, Jiang, Berggren-Söderlund, Maria, Nilsson-Ehle, Peter, Xu, Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141548/ https://www.ncbi.nlm.nih.gov/pubmed/21729290 http://dx.doi.org/10.1186/1476-511X-10-112 |
Ejemplares similares
-
Expression and localization of apolipoprotein M in human colorectal tissues
por: Luo, Guanghua, et al.
Publicado: (2010) -
Apolipoprotein M
por: Luo, Guanghua, et al.
Publicado: (2004) -
Hyperglycemia-induced downregulation of apolipoprotein M expression is not via the hexosamine pathway
por: Jiang, Bo, et al.
Publicado: (2015) -
Decreased Activities of Apolipoprotein M Promoter Are Associated with the Susceptibility to Coronary Artery Diseases
por: Zheng, Lu, et al.
Publicado: (2014) -
TO901317 regulating apolipoprotein M expression mediates via the farnesoid X receptor pathway in Caco-2 cells
por: Zhu, Chunhua, et al.
Publicado: (2011)